nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—ND1—oviduct—ovarian cancer	0.0232	0.0915	CbGeAlD
Sevoflurane—KCNK3—female reproductive system—ovarian cancer	0.00625	0.0246	CbGeAlD
Sevoflurane—ATP5D—myometrium—ovarian cancer	0.00599	0.0236	CbGeAlD
Sevoflurane—ATP2C1—myometrium—ovarian cancer	0.00591	0.0233	CbGeAlD
Sevoflurane—KCNK2—vagina—ovarian cancer	0.00585	0.0231	CbGeAlD
Sevoflurane—KCNK2—testis—ovarian cancer	0.00522	0.0206	CbGeAlD
Sevoflurane—ND1—gonad—ovarian cancer	0.00485	0.0191	CbGeAlD
Sevoflurane—ATP5D—uterine cervix—ovarian cancer	0.00466	0.0184	CbGeAlD
Sevoflurane—ATP2C1—uterine cervix—ovarian cancer	0.0046	0.0181	CbGeAlD
Sevoflurane—GABRP—uterine cervix—ovarian cancer	0.00451	0.0178	CbGeAlD
Sevoflurane—ATP5D—decidua—ovarian cancer	0.00444	0.0175	CbGeAlD
Sevoflurane—GABRE—myometrium—ovarian cancer	0.00442	0.0174	CbGeAlD
Sevoflurane—ATP2C1—decidua—ovarian cancer	0.00438	0.0173	CbGeAlD
Sevoflurane—ND1—female reproductive system—ovarian cancer	0.00433	0.0171	CbGeAlD
Sevoflurane—GABRP—decidua—ovarian cancer	0.0043	0.0169	CbGeAlD
Sevoflurane—ATP5D—endometrium—ovarian cancer	0.00422	0.0166	CbGeAlD
Sevoflurane—ATP2C1—endometrium—ovarian cancer	0.00416	0.0164	CbGeAlD
Sevoflurane—ND1—bone marrow—ovarian cancer	0.00409	0.0161	CbGeAlD
Sevoflurane—GABRP—endometrium—ovarian cancer	0.00408	0.0161	CbGeAlD
Sevoflurane—GRIA1—testis—ovarian cancer	0.00407	0.016	CbGeAlD
Sevoflurane—ND1—female gonad—ovarian cancer	0.00394	0.0155	CbGeAlD
Sevoflurane—GABRG3—testis—ovarian cancer	0.00394	0.0155	CbGeAlD
Sevoflurane—ATP5D—gonad—ovarian cancer	0.00391	0.0154	CbGeAlD
Sevoflurane—ATP5D—uterus—ovarian cancer	0.00388	0.0153	CbGeAlD
Sevoflurane—ATP2C1—gonad—ovarian cancer	0.00386	0.0152	CbGeAlD
Sevoflurane—ATP2C1—uterus—ovarian cancer	0.00383	0.0151	CbGeAlD
Sevoflurane—KCNK2—lymph node—ovarian cancer	0.00379	0.0149	CbGeAlD
Sevoflurane—GABRP—uterus—ovarian cancer	0.00376	0.0148	CbGeAlD
Sevoflurane—ND1—testis—ovarian cancer	0.0035	0.0138	CbGeAlD
Sevoflurane—ATP5D—female reproductive system—ovarian cancer	0.00349	0.0138	CbGeAlD
Sevoflurane—ATP2C1—female reproductive system—ovarian cancer	0.00345	0.0136	CbGeAlD
Sevoflurane—GABRE—uterine cervix—ovarian cancer	0.00344	0.0136	CbGeAlD
Sevoflurane—GABRB1—vagina—ovarian cancer	0.00341	0.0134	CbGeAlD
Sevoflurane—GABRP—female reproductive system—ovarian cancer	0.00338	0.0133	CbGeAlD
Sevoflurane—ATP5D—bone marrow—ovarian cancer	0.0033	0.013	CbGeAlD
Sevoflurane—GABRE—decidua—ovarian cancer	0.00328	0.0129	CbGeAlD
Sevoflurane—GABRD—testis—ovarian cancer	0.00326	0.0129	CbGeAlD
Sevoflurane—ATP2C1—bone marrow—ovarian cancer	0.00325	0.0128	CbGeAlD
Sevoflurane—ATP5D—female gonad—ovarian cancer	0.00318	0.0125	CbGeAlD
Sevoflurane—ATP5D—vagina—ovarian cancer	0.00316	0.0124	CbGeAlD
Sevoflurane—ATP2C1—female gonad—ovarian cancer	0.00314	0.0124	CbGeAlD
Sevoflurane—ATP2C1—vagina—ovarian cancer	0.00312	0.0123	CbGeAlD
Sevoflurane—GABRE—endometrium—ovarian cancer	0.00311	0.0123	CbGeAlD
Sevoflurane—GABRP—vagina—ovarian cancer	0.00306	0.012	CbGeAlD
Sevoflurane—GABRA5—testis—ovarian cancer	0.00303	0.0119	CbGeAlD
Sevoflurane—GABRA3—testis—ovarian cancer	0.00282	0.0111	CbGeAlD
Sevoflurane—ATP5D—testis—ovarian cancer	0.00282	0.0111	CbGeAlD
Sevoflurane—ATP2C1—testis—ovarian cancer	0.00278	0.011	CbGeAlD
Sevoflurane—CYP2A6—vagina—ovarian cancer	0.00266	0.0105	CbGeAlD
Sevoflurane—GABRE—female reproductive system—ovarian cancer	0.00258	0.0102	CbGeAlD
Sevoflurane—ND1—lymph node—ovarian cancer	0.00253	0.00999	CbGeAlD
Sevoflurane—GABRB3—gonad—ovarian cancer	0.00245	0.00965	CbGeAlD
Sevoflurane—GABRA2—vagina—ovarian cancer	0.00235	0.00927	CbGeAlD
Sevoflurane—GABRE—female gonad—ovarian cancer	0.00235	0.00925	CbGeAlD
Sevoflurane—GABRE—vagina—ovarian cancer	0.00233	0.00919	CbGeAlD
Sevoflurane—GABRB2—testis—ovarian cancer	0.0023	0.00906	CbGeAlD
Sevoflurane—GABRB3—female reproductive system—ovarian cancer	0.00219	0.00862	CbGeAlD
Sevoflurane—GABRE—testis—ovarian cancer	0.00208	0.0082	CbGeAlD
Sevoflurane—ATP5D—lymph node—ovarian cancer	0.00204	0.00805	CbGeAlD
Sevoflurane—ATP2C1—lymph node—ovarian cancer	0.00202	0.00795	CbGeAlD
Sevoflurane—ALB—testis—ovarian cancer	0.0019	0.00748	CbGeAlD
Sevoflurane—GABRB3—testis—ovarian cancer	0.00176	0.00695	CbGeAlD
Sevoflurane—CYP2B6—gonad—ovarian cancer	0.00166	0.00654	CbGeAlD
Sevoflurane—GABRA2—lymph node—ovarian cancer	0.00152	0.006	CbGeAlD
Sevoflurane—GABRE—lymph node—ovarian cancer	0.00151	0.00595	CbGeAlD
Sevoflurane—CYP2B6—female reproductive system—ovarian cancer	0.00148	0.00584	CbGeAlD
Sevoflurane—CYP2E1—female reproductive system—ovarian cancer	0.00139	0.00548	CbGeAlD
Sevoflurane—ALB—lymph node—ovarian cancer	0.00138	0.00542	CbGeAlD
Sevoflurane—CYP2B6—vagina—ovarian cancer	0.00134	0.00528	CbGeAlD
Sevoflurane—CYP2B6—testis—ovarian cancer	0.0012	0.00471	CbGeAlD
Sevoflurane—CYP2E1—testis—ovarian cancer	0.00112	0.00442	CbGeAlD
Sevoflurane—CYP3A4—female reproductive system—ovarian cancer	0.00112	0.00441	CbGeAlD
Sevoflurane—Chills—Paclitaxel—ovarian cancer	0.00105	0.00189	CcSEcCtD
Sevoflurane—Renal failure acute—Epirubicin—ovarian cancer	0.00105	0.00188	CcSEcCtD
Sevoflurane—Arrhythmia—Paclitaxel—ovarian cancer	0.00105	0.00188	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00105	0.00188	CcSEcCtD
Sevoflurane—Hypersensitivity—Melphalan—ovarian cancer	0.00104	0.00187	CcSEcCtD
Sevoflurane—Asthenia—Topotecan—ovarian cancer	0.00104	0.00186	CcSEcCtD
Sevoflurane—Vomiting—Chlorambucil—ovarian cancer	0.00103	0.00186	CcSEcCtD
Sevoflurane—Mental disorder—Paclitaxel—ovarian cancer	0.00103	0.00184	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00102	0.00184	CcSEcCtD
Sevoflurane—Pruritus—Topotecan—ovarian cancer	0.00102	0.00184	CcSEcCtD
Sevoflurane—Malnutrition—Paclitaxel—ovarian cancer	0.00102	0.00183	CcSEcCtD
Sevoflurane—Feeling abnormal—Vinorelbine—ovarian cancer	0.00102	0.00183	CcSEcCtD
Sevoflurane—Asthenia—Melphalan—ovarian cancer	0.00102	0.00183	CcSEcCtD
Sevoflurane—Pruritus—Melphalan—ovarian cancer	0.001	0.0018	CcSEcCtD
Sevoflurane—Tension—Paclitaxel—ovarian cancer	0.001	0.0018	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.001	0.0018	CcSEcCtD
Sevoflurane—Dysgeusia—Paclitaxel—ovarian cancer	0.000998	0.00179	CcSEcCtD
Sevoflurane—Haemoglobin—Docetaxel—ovarian cancer	0.000998	0.00179	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—ovarian cancer	0.000996	0.00179	CcSEcCtD
Sevoflurane—Haemorrhage—Docetaxel—ovarian cancer	0.000993	0.00178	CcSEcCtD
Sevoflurane—Hepatitis—Docetaxel—ovarian cancer	0.000993	0.00178	CcSEcCtD
Sevoflurane—Nervousness—Paclitaxel—ovarian cancer	0.00099	0.00178	CcSEcCtD
Sevoflurane—Pharyngitis—Docetaxel—ovarian cancer	0.000985	0.00177	CcSEcCtD
Sevoflurane—Urticaria—Vinorelbine—ovarian cancer	0.000983	0.00177	CcSEcCtD
Sevoflurane—Urinary tract disorder—Docetaxel—ovarian cancer	0.00098	0.00176	CcSEcCtD
Sevoflurane—Body temperature increased—Vinorelbine—ovarian cancer	0.000978	0.00176	CcSEcCtD
Sevoflurane—Urethral disorder—Docetaxel—ovarian cancer	0.000973	0.00175	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—ovarian cancer	0.00097	0.00174	CcSEcCtD
Sevoflurane—Nausea—Chlorambucil—ovarian cancer	0.000965	0.00173	CcSEcCtD
Sevoflurane—Dizziness—Topotecan—ovarian cancer	0.000956	0.00172	CcSEcCtD
Sevoflurane—Agitation—Paclitaxel—ovarian cancer	0.000937	0.00168	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000925	0.00166	CcSEcCtD
Sevoflurane—Cardiac disorder—Docetaxel—ovarian cancer	0.000921	0.00166	CcSEcCtD
Sevoflurane—Cardiac arrest—Epirubicin—ovarian cancer	0.00092	0.00165	CcSEcCtD
Sevoflurane—Vomiting—Topotecan—ovarian cancer	0.000919	0.00165	CcSEcCtD
Sevoflurane—Syncope—Paclitaxel—ovarian cancer	0.000914	0.00164	CcSEcCtD
Sevoflurane—Rash—Topotecan—ovarian cancer	0.000912	0.00164	CcSEcCtD
Sevoflurane—Hypersensitivity—Vinorelbine—ovarian cancer	0.000911	0.00164	CcSEcCtD
Sevoflurane—Dermatitis—Topotecan—ovarian cancer	0.000911	0.00164	CcSEcCtD
Sevoflurane—Headache—Topotecan—ovarian cancer	0.000906	0.00163	CcSEcCtD
Sevoflurane—Angiopathy—Docetaxel—ovarian cancer	0.000901	0.00162	CcSEcCtD
Sevoflurane—Vomiting—Melphalan—ovarian cancer	0.0009	0.00162	CcSEcCtD
Sevoflurane—Immune system disorder—Docetaxel—ovarian cancer	0.000897	0.00161	CcSEcCtD
Sevoflurane—Loss of consciousness—Paclitaxel—ovarian cancer	0.000896	0.00161	CcSEcCtD
Sevoflurane—Mediastinal disorder—Docetaxel—ovarian cancer	0.000895	0.00161	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—ovarian cancer	0.000893	0.00161	CcSEcCtD
Sevoflurane—Rash—Melphalan—ovarian cancer	0.000893	0.0016	CcSEcCtD
Sevoflurane—Dermatitis—Melphalan—ovarian cancer	0.000892	0.0016	CcSEcCtD
Sevoflurane—Chills—Docetaxel—ovarian cancer	0.000891	0.0016	CcSEcCtD
Sevoflurane—Cough—Paclitaxel—ovarian cancer	0.00089	0.0016	CcSEcCtD
Sevoflurane—Asthenia—Vinorelbine—ovarian cancer	0.000887	0.0016	CcSEcCtD
Sevoflurane—Arrhythmia—Docetaxel—ovarian cancer	0.000887	0.00159	CcSEcCtD
Sevoflurane—Convulsion—Paclitaxel—ovarian cancer	0.000883	0.00159	CcSEcCtD
Sevoflurane—Hypertension—Paclitaxel—ovarian cancer	0.00088	0.00158	CcSEcCtD
Sevoflurane—Pruritus—Vinorelbine—ovarian cancer	0.000875	0.00157	CcSEcCtD
Sevoflurane—Mental disorder—Docetaxel—ovarian cancer	0.00087	0.00156	CcSEcCtD
Sevoflurane—Chest pain—Paclitaxel—ovarian cancer	0.000868	0.00156	CcSEcCtD
Sevoflurane—Malnutrition—Docetaxel—ovarian cancer	0.000864	0.00155	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000862	0.00155	CcSEcCtD
Sevoflurane—Nausea—Topotecan—ovarian cancer	0.000859	0.00154	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—ovarian cancer	0.000851	0.00153	CcSEcCtD
Sevoflurane—Dry mouth—Paclitaxel—ovarian cancer	0.000849	0.00153	CcSEcCtD
Sevoflurane—Dysgeusia—Docetaxel—ovarian cancer	0.000846	0.00152	CcSEcCtD
Sevoflurane—Nausea—Melphalan—ovarian cancer	0.000841	0.00151	CcSEcCtD
Sevoflurane—Confusional state—Paclitaxel—ovarian cancer	0.000839	0.00151	CcSEcCtD
Sevoflurane—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000832	0.0015	CcSEcCtD
Sevoflurane—Oedema—Paclitaxel—ovarian cancer	0.000832	0.0015	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000827	0.00149	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—ovarian cancer	0.00082	0.00147	CcSEcCtD
Sevoflurane—Shock—Paclitaxel—ovarian cancer	0.000819	0.00147	CcSEcCtD
Sevoflurane—Dizziness—Vinorelbine—ovarian cancer	0.000818	0.00147	CcSEcCtD
Sevoflurane—Nervous system disorder—Paclitaxel—ovarian cancer	0.000816	0.00147	CcSEcCtD
Sevoflurane—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000815	0.00146	CcSEcCtD
Sevoflurane—Tachycardia—Paclitaxel—ovarian cancer	0.000812	0.00146	CcSEcCtD
Sevoflurane—Skin disorder—Paclitaxel—ovarian cancer	0.000808	0.00145	CcSEcCtD
Sevoflurane—Vomiting—Vinorelbine—ovarian cancer	0.000786	0.00141	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—ovarian cancer	0.000782	0.00141	CcSEcCtD
Sevoflurane—Rash—Vinorelbine—ovarian cancer	0.00078	0.0014	CcSEcCtD
Sevoflurane—Dermatitis—Vinorelbine—ovarian cancer	0.000779	0.0014	CcSEcCtD
Sevoflurane—Hypotension—Paclitaxel—ovarian cancer	0.000777	0.0014	CcSEcCtD
Sevoflurane—Headache—Vinorelbine—ovarian cancer	0.000775	0.00139	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—ovarian cancer	0.000775	0.00139	CcSEcCtD
Sevoflurane—Loss of consciousness—Docetaxel—ovarian cancer	0.000759	0.00136	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—ovarian cancer	0.000759	0.00136	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—ovarian cancer	0.000754	0.00136	CcSEcCtD
Sevoflurane—Cough—Docetaxel—ovarian cancer	0.000754	0.00136	CcSEcCtD
Sevoflurane—Insomnia—Paclitaxel—ovarian cancer	0.000752	0.00135	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—ovarian cancer	0.000749	0.00135	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—ovarian cancer	0.000746	0.00134	CcSEcCtD
Sevoflurane—Dyspnoea—Paclitaxel—ovarian cancer	0.000742	0.00133	CcSEcCtD
Sevoflurane—Somnolence—Paclitaxel—ovarian cancer	0.00074	0.00133	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—ovarian cancer	0.000736	0.00132	CcSEcCtD
Sevoflurane—Nausea—Vinorelbine—ovarian cancer	0.000735	0.00132	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—ovarian cancer	0.000733	0.00132	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000731	0.00131	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—ovarian cancer	0.000727	0.00131	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—ovarian cancer	0.000725	0.0013	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—ovarian cancer	0.000724	0.0013	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—ovarian cancer	0.000719	0.00129	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000718	0.00129	CcSEcCtD
Sevoflurane—Pain—Paclitaxel—ovarian cancer	0.000711	0.00128	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—ovarian cancer	0.000711	0.00128	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000705	0.00127	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—ovarian cancer	0.000705	0.00127	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—ovarian cancer	0.000705	0.00127	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000698	0.00125	CcSEcCtD
Sevoflurane—Shock—Docetaxel—ovarian cancer	0.000694	0.00125	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—ovarian cancer	0.000692	0.00124	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—ovarian cancer	0.00069	0.00124	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—ovarian cancer	0.000688	0.00124	CcSEcCtD
Sevoflurane—Feeling abnormal—Paclitaxel—ovarian cancer	0.000686	0.00123	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—ovarian cancer	0.000685	0.00123	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—ovarian cancer	0.000682	0.00123	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—ovarian cancer	0.000678	0.00122	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—ovarian cancer	0.000673	0.00121	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—ovarian cancer	0.000673	0.00121	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—ovarian cancer	0.000671	0.00121	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—ovarian cancer	0.000669	0.0012	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—ovarian cancer	0.000669	0.0012	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—ovarian cancer	0.000664	0.00119	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—ovarian cancer	0.000661	0.00119	CcSEcCtD
Sevoflurane—Urticaria—Paclitaxel—ovarian cancer	0.000661	0.00119	CcSEcCtD
Sevoflurane—Hypotension—Docetaxel—ovarian cancer	0.000659	0.00118	CcSEcCtD
Sevoflurane—Body temperature increased—Paclitaxel—ovarian cancer	0.000658	0.00118	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—ovarian cancer	0.000656	0.00118	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000653	0.00117	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—ovarian cancer	0.000638	0.00115	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—ovarian cancer	0.000631	0.00113	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—ovarian cancer	0.000629	0.00113	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—ovarian cancer	0.000627	0.00113	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—ovarian cancer	0.000623	0.00112	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—ovarian cancer	0.000621	0.00112	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—ovarian cancer	0.000619	0.00111	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—ovarian cancer	0.000619	0.00111	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—ovarian cancer	0.000615	0.00111	CcSEcCtD
Sevoflurane—Hypersensitivity—Paclitaxel—ovarian cancer	0.000613	0.0011	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000612	0.0011	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000609	0.00109	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—ovarian cancer	0.000607	0.00109	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—ovarian cancer	0.000607	0.00109	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—ovarian cancer	0.000605	0.00109	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—ovarian cancer	0.000603	0.00108	CcSEcCtD
Sevoflurane—Pain—Docetaxel—ovarian cancer	0.000603	0.00108	CcSEcCtD
Sevoflurane—Chills—Epirubicin—ovarian cancer	0.000601	0.00108	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—ovarian cancer	0.000598	0.00107	CcSEcCtD
Sevoflurane—Asthenia—Paclitaxel—ovarian cancer	0.000597	0.00107	CcSEcCtD
Sevoflurane—Pruritus—Paclitaxel—ovarian cancer	0.000589	0.00106	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—ovarian cancer	0.000587	0.00105	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—ovarian cancer	0.000583	0.00105	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—ovarian cancer	0.000581	0.00104	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—ovarian cancer	0.000575	0.00103	CcSEcCtD
Sevoflurane—Tension—Epirubicin—ovarian cancer	0.000572	0.00103	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—ovarian cancer	0.000571	0.00103	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—ovarian cancer	0.000566	0.00102	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—ovarian cancer	0.000562	0.00101	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—ovarian cancer	0.00056	0.00101	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000558	0.001	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—ovarian cancer	0.000557	0.001	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—ovarian cancer	0.000556	0.000999	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—ovarian cancer	0.000553	0.000995	CcSEcCtD
Sevoflurane—Dizziness—Paclitaxel—ovarian cancer	0.00055	0.000989	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—ovarian cancer	0.000543	0.000975	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—ovarian cancer	0.000539	0.000969	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—ovarian cancer	0.000536	0.000963	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—ovarian cancer	0.000529	0.000951	CcSEcCtD
Sevoflurane—Vomiting—Paclitaxel—ovarian cancer	0.000529	0.000951	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—ovarian cancer	0.000528	0.000949	CcSEcCtD
Sevoflurane—Rash—Paclitaxel—ovarian cancer	0.000525	0.000943	CcSEcCtD
Sevoflurane—Dermatitis—Paclitaxel—ovarian cancer	0.000524	0.000942	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—ovarian cancer	0.000524	0.000941	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—ovarian cancer	0.000523	0.000939	CcSEcCtD
Sevoflurane—Headache—Paclitaxel—ovarian cancer	0.000521	0.000937	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—ovarian cancer	0.00052	0.000934	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—ovarian cancer	0.000512	0.000921	CcSEcCtD
Sevoflurane—Cough—Epirubicin—ovarian cancer	0.000509	0.000914	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—ovarian cancer	0.000506	0.000909	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—ovarian cancer	0.000505	0.000908	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—ovarian cancer	0.000503	0.000904	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—ovarian cancer	0.000499	0.000897	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—ovarian cancer	0.000496	0.000892	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—ovarian cancer	0.000496	0.000891	CcSEcCtD
Sevoflurane—Nausea—Paclitaxel—ovarian cancer	0.000494	0.000888	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000493	0.000886	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—ovarian cancer	0.000485	0.000872	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—ovarian cancer	0.000484	0.000869	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—ovarian cancer	0.00048	0.000862	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—ovarian cancer	0.000476	0.000855	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—ovarian cancer	0.000476	0.000855	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—ovarian cancer	0.000474	0.000852	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—ovarian cancer	0.000471	0.000846	CcSEcCtD
Sevoflurane—Shock—Epirubicin—ovarian cancer	0.000468	0.000841	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—ovarian cancer	0.000467	0.00084	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—ovarian cancer	0.000466	0.000838	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—ovarian cancer	0.000466	0.000838	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—ovarian cancer	0.000466	0.000837	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—ovarian cancer	0.000466	0.000837	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—ovarian cancer	0.000464	0.000834	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—ovarian cancer	0.000462	0.00083	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—ovarian cancer	0.000459	0.000825	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000456	0.000819	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—ovarian cancer	0.000449	0.000807	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—ovarian cancer	0.000448	0.000806	CcSEcCtD
Sevoflurane—Rash—Docetaxel—ovarian cancer	0.000445	0.000799	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—ovarian cancer	0.000444	0.000799	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—ovarian cancer	0.000444	0.000798	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—ovarian cancer	0.000444	0.000798	CcSEcCtD
Sevoflurane—Headache—Docetaxel—ovarian cancer	0.000442	0.000794	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—ovarian cancer	0.00044	0.000791	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00044	0.000791	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—ovarian cancer	0.000433	0.000778	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—ovarian cancer	0.000432	0.000776	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000431	0.000774	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—ovarian cancer	0.00043	0.000773	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—ovarian cancer	0.00043	0.000772	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—ovarian cancer	0.000427	0.000768	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—ovarian cancer	0.000424	0.000762	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—ovarian cancer	0.000423	0.00076	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—ovarian cancer	0.000419	0.000753	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—ovarian cancer	0.000411	0.000739	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000411	0.000738	CcSEcCtD
Sevoflurane—Pain—Epirubicin—ovarian cancer	0.000407	0.000731	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—ovarian cancer	0.000398	0.000715	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—ovarian cancer	0.000392	0.000705	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—ovarian cancer	0.000392	0.000704	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—ovarian cancer	0.000391	0.000703	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00038	0.000683	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—ovarian cancer	0.000378	0.000679	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—ovarian cancer	0.000376	0.000676	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—ovarian cancer	0.000376	0.000676	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—ovarian cancer	0.000363	0.000652	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—ovarian cancer	0.00035	0.00063	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—ovarian cancer	0.00035	0.000628	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—ovarian cancer	0.000348	0.000625	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—ovarian cancer	0.000341	0.000613	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—ovarian cancer	0.000337	0.000605	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—ovarian cancer	0.000324	0.000583	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—ovarian cancer	0.000316	0.000568	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—ovarian cancer	0.000315	0.000565	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—ovarian cancer	0.000311	0.00056	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—ovarian cancer	0.000302	0.000544	CcSEcCtD
Sevoflurane—Rash—Epirubicin—ovarian cancer	0.0003	0.000539	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—ovarian cancer	0.0003	0.000539	CcSEcCtD
Sevoflurane—Headache—Epirubicin—ovarian cancer	0.000298	0.000536	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—ovarian cancer	0.000291	0.000523	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—ovarian cancer	0.000283	0.000508	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—ovarian cancer	0.00028	0.000503	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—ovarian cancer	0.000277	0.000499	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—ovarian cancer	0.000277	0.000498	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—ovarian cancer	0.000276	0.000496	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—ovarian cancer	0.000261	0.00047	CcSEcCtD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000119	0.000625	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000119	0.000625	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000119	0.000624	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000118	0.000621	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000118	0.000621	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000118	0.000619	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ABCB1—ovarian cancer	0.000118	0.000619	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ABCB1—ovarian cancer	0.000118	0.000619	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000117	0.000618	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000117	0.000617	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000117	0.000616	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000117	0.000614	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000116	0.00061	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000116	0.00061	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TYMS—ovarian cancer	0.000115	0.000608	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TYMS—ovarian cancer	0.000115	0.000608	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000115	0.000603	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	0.000114	0.0006	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000114	0.0006	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000114	0.000599	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000112	0.000589	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000111	0.000586	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.000111	0.000584	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000111	0.000583	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—ovarian cancer	0.00011	0.00058	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NME2—ovarian cancer	0.00011	0.00058	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00011	0.00058	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.00011	0.000579	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000109	0.000575	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000109	0.000574	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NME2—ovarian cancer	0.000108	0.000568	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000105	0.000552	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000104	0.000549	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—MAPK1—ovarian cancer	0.000104	0.000548	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000103	0.000542	CbGpPWpGaD
Sevoflurane—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000103	0.00054	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000102	0.000537	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000101	0.000533	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000101	0.000529	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.0001	0.000527	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.99e-05	0.000526	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—ovarian cancer	9.96e-05	0.000524	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	9.88e-05	0.00052	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.77e-05	0.000514	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.71e-05	0.000511	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.59e-05	0.000505	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.53e-05	0.000502	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	9.49e-05	0.0005	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.42e-05	0.000496	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.41e-05	0.000496	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.37e-05	0.000493	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.36e-05	0.000493	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.31e-05	0.00049	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CAV1—ovarian cancer	9.3e-05	0.00049	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CAV1—ovarian cancer	9.3e-05	0.00049	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NME2—ovarian cancer	9.27e-05	0.000488	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.19e-05	0.000484	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	9.15e-05	0.000482	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.14e-05	0.000481	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.14e-05	0.000481	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.99e-05	0.000473	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.98e-05	0.000473	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.98e-05	0.000473	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.84e-05	0.000466	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.82e-05	0.000465	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYTB—ovarian cancer	8.8e-05	0.000463	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—ovarian cancer	8.78e-05	0.000462	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.77e-05	0.000462	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.61e-05	0.000453	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—MAPK1—ovarian cancer	8.57e-05	0.000451	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CG—ovarian cancer	8.47e-05	0.000446	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CG—ovarian cancer	8.47e-05	0.000446	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—MAPK1—ovarian cancer	8.44e-05	0.000444	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.37e-05	0.000441	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—ovarian cancer	8.35e-05	0.00044	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.26e-05	0.000435	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	8.21e-05	0.000432	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	8.1e-05	0.000426	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	8.08e-05	0.000426	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	8.04e-05	0.000423	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL6—ovarian cancer	8.04e-05	0.000423	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.99e-05	0.000421	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—MAPK1—ovarian cancer	7.99e-05	0.00042	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—MAPK1—ovarian cancer	7.89e-05	0.000415	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SPARC—ovarian cancer	7.87e-05	0.000414	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.87e-05	0.000414	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—BRIP1—ovarian cancer	7.69e-05	0.000405	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPP1CC—ovarian cancer	7.69e-05	0.000405	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.56e-05	0.000398	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.52e-05	0.000396	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CD—ovarian cancer	7.45e-05	0.000392	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CD—ovarian cancer	7.45e-05	0.000392	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	7.39e-05	0.000389	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.34e-05	0.000387	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—MAPK1—ovarian cancer	7.21e-05	0.00038	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.21e-05	0.00038	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYTB—ovarian cancer	7.1e-05	0.000374	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.08e-05	0.000373	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	7.05e-05	0.000371	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.04e-05	0.000371	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—MAPK1—ovarian cancer	7.01e-05	0.000369	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYTB—ovarian cancer	6.95e-05	0.000366	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.91e-05	0.000364	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—MAPK1—ovarian cancer	6.88e-05	0.000362	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—ovarian cancer	6.88e-05	0.000362	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—ovarian cancer	6.78e-05	0.000357	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—MAPK1—ovarian cancer	6.76e-05	0.000356	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—MAPK1—ovarian cancer	6.72e-05	0.000354	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—MAPK1—ovarian cancer	6.6e-05	0.000347	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	6.49e-05	0.000342	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CB—ovarian cancer	6.49e-05	0.000342	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CB—ovarian cancer	6.49e-05	0.000342	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.41e-05	0.000338	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—ovarian cancer	6.41e-05	0.000338	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	6.38e-05	0.000336	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—ovarian cancer	6.33e-05	0.000333	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—BRIP1—ovarian cancer	6.2e-05	0.000327	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPP1CC—ovarian cancer	6.2e-05	0.000327	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPP1CC—ovarian cancer	6.08e-05	0.00032	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—BRIP1—ovarian cancer	6.08e-05	0.00032	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.04e-05	0.000318	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6e-05	0.000316	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYTB—ovarian cancer	5.98e-05	0.000315	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.84e-05	0.000307	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.79e-05	0.000305	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—ovarian cancer	5.79e-05	0.000305	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—MAPK1—ovarian cancer	5.77e-05	0.000304	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SOD1—ovarian cancer	5.72e-05	0.000301	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PPP2R1A—ovarian cancer	5.69e-05	0.0003	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	5.66e-05	0.000298	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—ovarian cancer	5.62e-05	0.000296	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—ovarian cancer	5.61e-05	0.000295	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—ovarian cancer	5.61e-05	0.000295	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—ovarian cancer	5.52e-05	0.000291	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—ovarian cancer	5.43e-05	0.000286	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—ovarian cancer	5.39e-05	0.000284	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—ovarian cancer	5.3e-05	0.000279	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—BRIP1—ovarian cancer	5.22e-05	0.000275	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPP1CC—ovarian cancer	5.22e-05	0.000275	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	5.2e-05	0.000274	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—YAP1—ovarian cancer	5.16e-05	0.000272	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NME2—ovarian cancer	5.01e-05	0.000264	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—ovarian cancer	4.63e-05	0.000244	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.57e-05	0.000241	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	4.42e-05	0.000233	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—FASN—ovarian cancer	4.2e-05	0.000221	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CAV1—ovarian cancer	4.18e-05	0.00022	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	4.18e-05	0.00022	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—YAP1—ovarian cancer	4.16e-05	0.000219	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC5A5—ovarian cancer	4.14e-05	0.000218	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—YAP1—ovarian cancer	4.08e-05	0.000215	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC2A1—ovarian cancer	3.99e-05	0.00021	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	3.98e-05	0.000209	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—ovarian cancer	3.96e-05	0.000208	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—ovarian cancer	3.96e-05	0.000208	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1B1—ovarian cancer	3.83e-05	0.000202	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CG—ovarian cancer	3.81e-05	0.000201	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.81e-05	0.0002	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—YAP1—ovarian cancer	3.5e-05	0.000184	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.47e-05	0.000183	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	3.45e-05	0.000182	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	3.4e-05	0.000179	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—FASN—ovarian cancer	3.39e-05	0.000179	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CD—ovarian cancer	3.35e-05	0.000176	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC5A5—ovarian cancer	3.34e-05	0.000176	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—FASN—ovarian cancer	3.32e-05	0.000175	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC5A5—ovarian cancer	3.27e-05	0.000172	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—ovarian cancer	3.23e-05	0.00017	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—ovarian cancer	3.23e-05	0.00017	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYTB—ovarian cancer	3.23e-05	0.00017	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC2A1—ovarian cancer	3.22e-05	0.00017	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3.16e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—ovarian cancer	3.15e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMS—ovarian cancer	3.1e-05	0.000163	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.09e-05	0.000163	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.05e-05	0.00016	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1B1—ovarian cancer	3.03e-05	0.000159	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CB—ovarian cancer	2.92e-05	0.000154	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—FASN—ovarian cancer	2.86e-05	0.00015	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.82e-05	0.000148	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.82e-05	0.000148	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	2.82e-05	0.000148	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC5A5—ovarian cancer	2.81e-05	0.000148	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	2.74e-05	0.000144	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC2A1—ovarian cancer	2.71e-05	0.000143	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	2.68e-05	0.000141	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—ovarian cancer	2.68e-05	0.000141	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.66e-05	0.00014	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1B1—ovarian cancer	2.6e-05	0.000137	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—ovarian cancer	2.54e-05	0.000134	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMS—ovarian cancer	2.5e-05	0.000132	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CAV1—ovarian cancer	2.5e-05	0.000131	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.49e-05	0.000131	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMS—ovarian cancer	2.45e-05	0.000129	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPP2R1A—ovarian cancer	2.31e-05	0.000121	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.3e-05	0.000121	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—ovarian cancer	2.28e-05	0.00012	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.27e-05	0.00012	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—ovarian cancer	2.25e-05	0.000118	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK3—ovarian cancer	2.15e-05	0.000113	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—ovarian cancer	2.14e-05	0.000113	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMS—ovarian cancer	2.1e-05	0.000111	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK1—ovarian cancer	2.05e-05	0.000108	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CAV1—ovarian cancer	2.01e-05	0.000106	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CD—ovarian cancer	2e-05	0.000105	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CAV1—ovarian cancer	1.97e-05	0.000104	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—ovarian cancer	1.94e-05	0.000102	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—YAP1—ovarian cancer	1.89e-05	9.96e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.83e-05	9.66e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.8e-05	9.46e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—ovarian cancer	1.78e-05	9.37e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CB—ovarian cancer	1.74e-05	9.17e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—ovarian cancer	1.72e-05	9.06e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CAV1—ovarian cancer	1.7e-05	8.92e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—ovarian cancer	1.65e-05	8.66e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.62e-05	8.53e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.61e-05	8.49e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.58e-05	8.32e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CG—ovarian cancer	1.54e-05	8.13e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—FASN—ovarian cancer	1.54e-05	8.12e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.52e-05	7.98e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—ovarian cancer	1.51e-05	7.92e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.46e-05	7.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—ovarian cancer	1.45e-05	7.65e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.41e-05	7.4e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.4e-05	7.39e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.38e-05	7.25e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CD—ovarian cancer	1.36e-05	7.15e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.25e-05	6.56e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—ovarian cancer	1.21e-05	6.39e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—ovarian cancer	1.19e-05	6.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CB—ovarian cancer	1.18e-05	6.23e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.16e-05	6.09e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMS—ovarian cancer	1.14e-05	5.98e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.06e-05	5.59e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—ovarian cancer	1.02e-05	5.38e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CAV1—ovarian cancer	9.15e-06	4.82e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—ovarian cancer	8.67e-06	4.57e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—ovarian cancer	8.57e-06	4.51e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—ovarian cancer	8.39e-06	4.42e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CG—ovarian cancer	8.33e-06	4.39e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CD—ovarian cancer	7.33e-06	3.86e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—ovarian cancer	7.21e-06	3.8e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—ovarian cancer	7e-06	3.69e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—ovarian cancer	6.86e-06	3.61e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CB—ovarian cancer	6.39e-06	3.36e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—ovarian cancer	5.89e-06	3.1e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—ovarian cancer	5.52e-06	2.91e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.89e-06	2.05e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—ovarian cancer	3.18e-06	1.67e-05	CbGpPWpGaD
